Multiple Sclerosis (MS) is an inflammatory disease that affects more than 2.3 million people. While each person experiences the disease differently, common symptoms include headaches, fatigue, weakness, and tingling in the body.
Kesimpta is a new FDA approved treatment for relapsing MS. The treatment is monthly and self administered, and can help address some common symptoms.
Learn more here.